[Clinical features and gene mutation spectrum in children with sideroblastic anemia] - PubMed

Objective: To study the clinical features and gene mutation spectrum of children with sideroblastic anemia (SA) and the clinical value of targeted next-generation sequencing in the molecular diagnosis of children with SA.

Methods: Clinical data were collected from 36 children with SA. Targeted next-generation sequencing was used to detect mutations in SA-related pathogenic genes and genes associated with heme synthesis and mitochondrial iron metabolism. The association between genotype and clinical phenotype was analyzed.

Results: Of the 36 patients, 32 had congenital sideroblastic anemia (CSA) and 4 had myelodysplastic syndrome with ring sideroblasts (MDS-RS). Mutations in CSA-related genes were detected in 19 children (19/36, 53%), among whom 9 (47%) had ALAS2 mutation, 4 (21%) had SLC25A38 mutation, and 6 (32%) had mitochondrial fragment deletion. No pathogenic gene mutation was detected in 4 children with MDS-RS. Among the 19 mutations, 89% (17/19) were known mutations and 11% (2/19) were novel mutations. The novel mutation of the ALAS2 gene c.1153A>T(p.I385F) was rated as "possibly pathogenic" and the novel mutation of the SLC25A38 gene c.175C>T(p.Q59X) was rated as "pathogenic".

Conclusions: ALAS2 and SLC25A38 gene mutations are commonly seen in children with CSA, but mitochondrial gene fragment deletion also accounts for a relatively high proportion. For children with hypoplastic anemia occurring in infancy, mitochondrial disease should be considered.

目的: 对铁粒幼红细胞贫血（SA）患儿的临床特征和基因突变谱进行分析，探讨目的基因捕获二代测序技术在SA患儿分子诊断中的临床应用价值，提高对SA的早期诊断和临床干预水平。

方法: 收集36例诊断为SA患儿的临床资料，采用目的基因捕获二代测序方法进行SA相关致病基因、与血红素合成及线粒体铁代谢有关的基因检测，分析基因型与临床表型的关系。

结果: 36例患儿中，32例为遗传性铁粒幼红细胞贫血（CSA），4例为骨髓增生异常综合征伴环形铁粒幼红细胞（MDS-RS）。共53%（19/36）患儿检测到CSA相关基因突变，其中ALAS2基因突变占47%（9/19），SLC25A38基因突变占21%（4/19），线粒体片段缺失占32%（6/19）。所有MDS-RS患儿均未检测到致病/可能致病性基因突变。89%（17/19）为已知致病突变，11%（2/19）为新变异。ALAS2基因新变异c.1153A > T（p.I385F）评级为"可能致病的"及SLC25A38基因新变异c.175C > T（p.Q59X）评级为"致病的"。

结论: 儿童CSA以ALAS2及SLC25A38基因突变为主，但线粒体基因片段缺失亦占有相当比例，对于婴儿期即出现的低增生性贫血，需考虑线粒体病的可能。

1. 1. 龙 章彪, 杜 亚丽, 韩 冰. 遗传性铁粒幼细胞贫血相关基因及机制研究进展. 中华血液学杂志. 2016;37(12):1090–1093. doi: 10.3760/cma.j.issn.0253-2727.2016.12.018. - DOI
2. 1. Ducamp S, Fleming MD. The molecular genetics of sideroblastic anemia. Blood. 2019;133(1):59–69. doi: 10.1182/blood-2018-08-815951. - DOI - PMC - PubMed
3. 1. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. doi: 10.1182/blood-2016-03-643544. - DOI - PubMed
4. 1. Ohba R, Furuyama K, Yoshida K, et al. Clinical and genetic characteristics of congenital sideroblastic anemia:comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS) Ann Hematol. 2013;92(1):1–9. doi: 10.1007/s00277-012-1564-5. - DOI - PMC - PubMed
5. 1. Liu G, Guo S, Kang H, et al. Mutation spectrum in Chinese patients affected by congenital sideroblastic anemia and a search for a genotype-phenotype relationship. Haematologica. 2013;98(12):e158–e160. doi: 10.3324/haematol.2013.095513. - DOI - PMC - PubMed